A major discovery in cancer investigation is arising with the use of mini-antibodies to reactivate damaged p53. This essential cancer suppressor protein is frequently disabled in several forms of malignancies, causing https://sparxsocial.com/story792923/vhh-fragments-revive-p53-the-new-pathway-for-tumor-management